DR. SCOTT A WASHBURN, MD
Medical Practice at Lyndhurst Ave, Winston Salem, NC
License number
North Carolina 38709
Category
Medical Practice
Type
Obstetrics & Gynecology
Address
Address
2927 Lyndhurst Ave, Winston Salem, NC 27103
Phone
(336) 765-9350
(336) 760-4255 (Fax)
(336) 760-4255 (Fax)
Personal information
See more information about SCOTT A WASHBURN at radaris.comName
Address
Phone
5930 Glad Acres Rd, Pfafftown, NC 27040
116 Britt Ct Foxcroft, Chapel Hill, NC 27514
21503 Shearer Rd, Davidson, NC 28036
206 Port Royal Dr, Matthews, NC 28105
19001 Callaway Hills Ln, Davidson, NC 28036
Organization information
See more information about SCOTT A WASHBURN at bizstanding.comScott Washburn MD
2927 Lyndhurst Ave, Winston Salem, NC 27103
Industry:
Obgyn
Site:
Phone:
(336) 765-9350 (Phone)
Scott Alan Washburn
Lyndhurst Gynecologic Associate - Scott A Washburn MD
2927 Lyndhurst Ave, Winston Salem, NC 27103
Categories:
Gynecology & Obstetrics Physicians & Surgeons, Physicians & Surgeons
Phone:
(336) 765-9350 (Phone)
Professional information
Dr. Scott A Washburn, Kernersville NC - MD (Doctor of Medicine)
Specialties:
Obstetrics & Gynecology
Address:
Lyndhurst Gynecologic Assocs
445 Pineview Dr SUITE 110, Kernersville 27284
(336) 993-4532 (Phone)
Lyndhurst Gynecologic Assocs
1908 Caudle Dr SUITE 101, Mount Airy 27030
(336) 789-9076 (Phone)
Lyndhurst Gynecologic Assocs
2927 Lyndhurst Ave, Winston Salem 27103
(336) 765-9350 (Phone)
445 Pineview Dr SUITE 110, Kernersville 27284
(336) 993-4532 (Phone)
Lyndhurst Gynecologic Assocs
1908 Caudle Dr SUITE 101, Mount Airy 27030
(336) 789-9076 (Phone)
Lyndhurst Gynecologic Assocs
2927 Lyndhurst Ave, Winston Salem 27103
(336) 765-9350 (Phone)
Certifications:
Obstetrics & Gynecology, 2010
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
Lyndhurst Gynecologic Assocs
445 Pineview Dr SUITE 110, Kernersville 27284
Lyndhurst Gynecologic Assocs
1908 Caudle Dr SUITE 101, Mount Airy 27030
Lyndhurst Gynecologic Assocs
2927 Lyndhurst Ave, Winston Salem 27103
Novant Health Forsyth Medical Center
3333 Silas Creek Pkwy, Winston Salem 27103
445 Pineview Dr SUITE 110, Kernersville 27284
Lyndhurst Gynecologic Assocs
1908 Caudle Dr SUITE 101, Mount Airy 27030
Lyndhurst Gynecologic Assocs
2927 Lyndhurst Ave, Winston Salem 27103
Novant Health Forsyth Medical Center
3333 Silas Creek Pkwy, Winston Salem 27103
Education:
Medical School
University of Arkansas For Medical Sciences
Graduated: 1986
Norfolk Genl Hosp-Eastern Va Med Sch
University of Arkansas For Medical Sciences
Graduated: 1986
Norfolk Genl Hosp-Eastern Va Med Sch
Scott Alan Washburn, Winston Salem NC
Specialties:
Obstetrics & Gynecology, Gynecology, Obstetrics
Work:
Lyndhurst Gynecological Associates Whap
2927 Lyndhurst Ave, Winston Salem, NC 27103 Lyndhurst Gynecologic Assoc PA
445 Pineview Dr, Kernersville, NC 27284 Lyndhurst Gynecologic Assoc PA
933 Old Rockford St, Mount Airy, NC 27030
2927 Lyndhurst Ave, Winston Salem, NC 27103 Lyndhurst Gynecologic Assoc PA
445 Pineview Dr, Kernersville, NC 27284 Lyndhurst Gynecologic Assoc PA
933 Old Rockford St, Mount Airy, NC 27030
Education:
University of Arkansas(1986)
Effects Of 17 .Alpha.-Dihydroequilenin On Plasma Lipid And Lipoprotein, Glucose, Insulin Concentrations, Coronary Artery Vasomotor Function, And Reproductive Organ And Mammary Gland Proliferation In Atherosclerotic Mammals
US Patent:
6207659, Mar 27, 2001
Filed:
Sep 9, 1999
Appl. No.:
9/392191
Inventors:
Scott A. Washburn - Winston-Salem NC
Thomas B. Clarkson - Clemmons NC
Michael R. Adams - Clemmons NC
Thomas C. Register - Clemmons NC
J. Koudy Williams - Clemmons NC
Janice D. Wagner - Kernersville NC
J. Mark Cline - Winston-Salem NC
Steven J. Adelman - Hatfield PA
Thomas B. Clarkson - Clemmons NC
Michael R. Adams - Clemmons NC
Thomas C. Register - Clemmons NC
J. Koudy Williams - Clemmons NC
Janice D. Wagner - Kernersville NC
J. Mark Cline - Winston-Salem NC
Steven J. Adelman - Hatfield PA
Assignee:
Wake Forest University - Winston-Salem NC
American Home Products Corporation - Madison NJ
American Home Products Corporation - Madison NJ
International Classification:
A61K31/56
US Classification:
514182
Abstract:
The present invention relates to a method of using 17. alpha. -dihydroequilenin and metabolic conjugates thereof to prevent and reduce atherogenesis in males and females without causing endometrial proliferation in females and without producing feminizing changes in males. 17. alpha. -dihydroequilenin was evaluated for its effects on plasma lipid and lipoprotein, glucose, insulin concentrations, coronary artery vasomotor function, and reproductive organ and mammary gland proliferation in atherosclerotic mammals. 17. alpha. -dihydroequilenin was found to prevent endothelium-dependent vasoconstriction in males (p<0. 05) and ovariectomized females (p<0. 08). 17. alpha. -dihydroequilenin treatment increased plasma apolipoprotein A-1 concentrations (p<0. 05) and lowered fasting insulin concentrations (p<0. 05) without changing fasting plasma glucose concentrations in males. 17. alpha.
Effects Of 17.Alpha.-Dihydroequilenin On Plasma Lipid And Lipoprotein, Glucose, Insulin Concentrations, Coronary Artery Vasomotor Function, And Reproductive Organ And Mammary Gland Proliferation In Atherosclerotic Mammals
US Patent:
5994337, Nov 30, 1999
Filed:
Jan 12, 1998
Appl. No.:
9/006000
Inventors:
Scott A. Washburn - Winston-Salem NC
Thomas B. Clarkson - Clemmons NC
Michael R. Adams - Clemmons NC
Thomas C. Register - Clemmons NC
J. Koudy Williams - Clemmons NC
Janice D. Wagner - Kernersville NC
J. Mark Cline - Winston-Salem NC
Steven J. Adelman - Hatfield PA
Thomas B. Clarkson - Clemmons NC
Michael R. Adams - Clemmons NC
Thomas C. Register - Clemmons NC
J. Koudy Williams - Clemmons NC
Janice D. Wagner - Kernersville NC
J. Mark Cline - Winston-Salem NC
Steven J. Adelman - Hatfield PA
Assignee:
Wake Forest University - Winston-Salem NC
American Home Products Corporation - Madison NJ
American Home Products Corporation - Madison NJ
International Classification:
A61K 3156
US Classification:
514182
Abstract:
The present invention relates to a method of using 17. alpha. -dihydroequilenin and metabolic conjugates thereof to prevent and reduce atherogenesis in males and females without causing endometrial proliferation in females and without producing feminizing changes in males. 17. alpha. -dihydroequilenin was evaluated for its effects on plasma lipid and lipoprotein, glucose, insulin concentrations, coronary artery vasomotor function, and reproductive organ and mammary gland proliferation in atherosclerotic mammals. 17. alpha. -dihydroequilenin was found to prevent endothelium-dependent vasoconstriction in males (p<0. 05) and ovariectomized females (p<0. 08). 17. alpha. -dihydroequilenin treatment increased plasma apolipoprotein A-l concentrations (p<0. 05) and lowered fasting insulin concentrations (p<0. 05) without changing fasting plasma glucose concentrations in males. 17. alpha.
Effects Of 17.Alpha.-Dihydroequilenin On Plasma Lipid And Lipoprotein, Glucose, Insulin Concentrations, Coronary Artery Vasomotor Function, And Reproductive Organ And Mammary Gland Proliferation In Atherosclerotic Mammals
US Patent:
6147069, Nov 14, 2000
Filed:
Sep 9, 1999
Appl. No.:
9/391985
Inventors:
Scott A. Washburn - Winston-Salem NC
Thomas B. Clarkson - Clemmons NC
Michael R. Adams - Clemmons NC
Thomas C. Register - Clemmons NC
J. Koudy Williams - Clemmons NC
Janice D. Wagner - Kernersville NC
J. Mark Cline - Winston-Salem NC
Steven J. Adelman - Hatfield PA
Thomas B. Clarkson - Clemmons NC
Michael R. Adams - Clemmons NC
Thomas C. Register - Clemmons NC
J. Koudy Williams - Clemmons NC
Janice D. Wagner - Kernersville NC
J. Mark Cline - Winston-Salem NC
Steven J. Adelman - Hatfield PA
Assignee:
Wake Forest University - Winston-Salem NC
American Home Products Corporation - Madison NJ
American Home Products Corporation - Madison NJ
International Classification:
A61K 3156
US Classification:
514182
Abstract:
The present invention relates to a method of using 17. alpha. -dihydroequilenin and metabolic conjugates thereof to prevent and reduce atherogenesis in males and females without causing endometrial proliferation in females and without producing feminizing changes in males. 17. alpha. -dihydroequilenin was evaluated for its effects on plasma lipid and lipoprotein, glucose, insulin concentrations, coronary artery vasomotor function, and reproductive organ and mammary gland proliferation in atherosclerotic mammals. 17. alpha. -dihydroequilenin was found to prevent endothelium-dependent vasoconstriction in males (p<0. 05) and ovariectomized females (p<0. 08). 17. alpha. -dihydroequilenin treatment increased plasma apolipoprotein A-1 concentrations (p<0. 05) and lowered fasting insulin concentrations (p<0. 05) without changing fasting plasma glucose concentrations in males. 17. alpha.
Method Of Preventing Neurodegeneration And Cognitive Dysfunction Using 17.Alpha.-Dihydroequilenin
US Patent:
5719137, Feb 17, 1998
Filed:
Dec 3, 1996
Appl. No.:
8/753988
Inventors:
Scott A. Washburn - Winston-Salem NC
Carol Ann Shively - Winston-Salem NC
Carol Ann Shively - Winston-Salem NC
Assignee:
Wake Forest University - Winston-Salem NC
International Classification:
A61K 3156
US Classification:
514182
Abstract:
A method of using a steroidal compound, 17. alpha. -dihydroequilenin, to prevent and treat neurodegeneration and cognitive dysfunction in estrogen deficient females and to reduce the risk of Alzheimer's related dementia and other senile dementia related conditions in both males and females. The method comprises administering 17. alpha. -dihydroequilenin in a therapeutically effective amount to a mammal in need of increased cognitive function or to a mammal susceptible to estrogen deficiency-related neurodegeneration or to senile dementia of the Alzheimer's type.